For Quick Alerts
For Daily Alerts

Unichem Lab Shares Surge Further By 4.5 Per cent

By Super

Mumbai, Mar 10 (PTI) Shares of Unichem Laboratories further surged by 4.5 per cent today following the USFDA nod for generic Quetiapine Fumarate tablets used for the treatment of schizophrenia and bipolar disorder.

Extending its previous session's rally, the stock rose by 4.5 per cent to Rs 241.40 on BSE. On NSE, it gained 4.51 per cent to Rs 242.

Unichem Lab Shares Surge Further By 4.5 Per cent
Unichem Laboratories: Quotes, News
BSE 188.80BSE Quote1.65 (-0.87%)
NSE 188.15NSE Quote2.05 (-1.09%)

In the previous session also the stock had soared up to 3.5 per cent. "The company has received Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration (USFDA) for Quetiapine Fumarate tablets," Unichem Laboratories had said in a BSE filing yesterday.

The approval is for the company's tablets in strengths of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg, it added.

"The product will be commercialised from Unichem's Ghaziabad plant. Active Pharmaceutical Ingredient will also be made in house at Pithampur API plant," the company had said.


Read more about: unichem laboratories
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more